Company intelligence / Profile preview

Previa Medical

Lyon, Auvergne-Rhône-Alpes, Franceprevia.it ↗

Ownership: Private
Development stage: Other

Overview

Previa Medical has developed SEPSI Score©, an AI-powered digital biomarker solution for early detection of sepsis in hospital settings. Retrospective studies have demonstrated its ability to predict sepsis up to 48 hours before symptom onset. The company has published results in peer-reviewed journals and completed cybersecurity audits. Clinical trials are ongoing as part of commercial launch preparation.

Therapeutic areas: Infectious Diseases
Modalities: Non-pharmacological therapyDigital biomarker platformArtificial intelligence-based risk prediction tool (not a drug/device in the traditional sense)
Industry: Digital Health Medical Devices

Partnerships

AlgoSecure (cybersecurity audit partner)

Beyond the preview

Go deeper on Previa Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Previa Medical.

Explore the full profile